FrancophonIA/ELRC3.0 huggingface dataset:
English: It also recommended that studies should be performed to determine the effects of Esmya on the liver and whether the new measures are effective in minimising the risks.
Croatian: Preporučuje se i provedba ispitivanja da bi se utvrdili učinci lijeka Esmya na jetru te jesu li nove mjere učinkovite u smanjenju rizika.
English: Certain women may start treatment with Esmya once the new measures are implemented.
Croatian: Određene bolesnice mogu započeti liječenje lijekom Esmya nakon provedbe novih mjera.
English: Ulipristal acetate is also the active substance of a single-dose medicine authorised for emergency contraception, ellaOne.
Croatian: Ulipristal acetat također je djelatna tvar jednokratne doze lijeka ellaOne, odobrenog za hitnu kontracepciju.
English: The measures include: contraindication in women with known liver problems; liver tests before, during and after stopping treatment; a card for patients to inform them about the need for liver monitoring and to contact their doctor should they develop symptoms of liver injury.
Croatian: Mjere uključuju sljedeće: kontraindikaciju u bolesnica s problemima jetre, jetrene probe prije, tijekom i nakon liječenja, karticu za bolesnike u kojima piše da je potrebno pratiti jetru i obratiti se liječniku u slučaju pojave simptoma oštećenja jetre.
English: The PRAC's recommendations have now been endorsed by EMA's Committee for Medicinal Products for Human Use (CHMP) and will be sent to the European Commission for a final legal decision.
Croatian: Preporuke PRAC-a podržao je EMA-in Odbor za lijekove za humanu uporabu (CHMP) i poslao ih Europskoj komisiji na konačnu pravnu odluku.
English: The PRAC's final recommendations were sent to the Committee for Medicinal Products for Human Use (CHMP), responsible for questions concerning medicines for human use, which adopted an opinion.
Croatian: Konačne preporuke PRAC-a poslane su Odboru za lijekove za humanu uporabu (CHMP), odgovornom za pitanja koja se odnose na lijekove za humanu uporabu, koji je usvojio mišljenje.
English: The PRAC concluded that Esmya may have contributed to the development of some cases of serious liver injury.1
Croatian: PRAC je zaključio da je lijek Esmya možda pridonio razvoju nekih slučajeva ozbiljna oštećenja jetre.1
English: • Healthcare professionals prescribing Esmya in the EU will receive a letter with further details once a European Commission decision has been issued.
Croatian: • Zdravstvenim radnicima koji propisuju lijek Esmya u EU-u poslan je dopis s dodatnim pojedinostima.
English: In addition, use of the medicine for more than one treatment course has been restricted to women who are not eligible for surgery.
Croatian: Nadalje, primjena lijeka u više ciklusa liječenja ograničena je na bolesnice koje ne ispunjavaju uvjete za operaciju.
English: Esmya: new measures to minimise risk of rare but serious liver injury
Croatian: Esmya: nove mjere za smanjenje opasnosti od rijetkog,
English: • You will also have liver tests during treatment and after treatment has stopped.
Croatian: • Pretrage jetre provodit će se i tijekom liječenja, kao i nakon liječenja.
English: Since progesterone may promote the growth of fibroids, by preventing the effects of progesterone ulipristal acetate reduces the size of the fibroids.
Croatian: Budući da progesteron može utjecati na rast mioma, ulipristal acetat smanjuje veličinu mioma inhibirajući učinak progesterona.
English: The active substance in Esmya, ulipristal acetate, works by attaching to the targets on cells (receptors) that the hormone progesterone normally attaches to, preventing progesterone from having its effect.
Croatian: Djelatna tvar lijeka Esmya, ulipristal acetat, djeluje vezivanjem na ciljne dijelove stanica (receptore) na koje se inače veže hormon progesteron, inhibirajući njegov učinak.
English: The review of Esmya was carried out by EMA's Pharmacovigilance Risk Assessment Committee (PRAC) following reports of serious liver injury, including liver failure leading to transplantation.
Croatian: Ocjenu lijeka Esmya proveo je EMA-in Odbor za ocjenu rizika na području farmakovigilancije (PRAC) nakon prijavljenih slučajeva ozbiljnog oštećenja jetre, uključujući zatajenje jetre koje je dovelo do transplantacije.
English: The review was carried out by the Pharmacovigilance Risk Assessment Committee (PRAC), the Committee responsible for the evaluation of safety issues for human medicines.
Croatian: Ocjenjivanje je proveo Odbor za procjenu rizika u području farmakovigilancije (PRAC), koji je odgovoran za procjenu sigurnosnih pitanja koja se odnose na lijekove za primjenu u ljudi.
English: Esmya was authorised in the EU in 2012 for the treatment of moderate to severe symptoms of uterine fibroids, which are benign (non-cancerous) tumours of the womb, in women who have not reached the menopause.
Croatian: Lijek Esmya odobren je u EU-u 2012. za liječenje umjerenih do teških simptoma mioma maternice, odnosno (nekanceroznih) dobroćudnih tumora maternice u žena koje još nisu u menopauzi.
English: EMA concludes review of medicine for uterine fibroids
Croatian: EMA zaključuje ocjenu lijeka za miome maternice
English: The European Medicines Agency (EMA) has recommended that several measures be put in place to minimise the risk of rare but serious liver injury with Esmya (ulipristal acetate).
Croatian: Europska agencija za lijekove (EMA) 31. svibnja 2018. izdala je preporuku za uvođenje nekoliko mjera za smanjenje opasnosti od rijetkog, ali ozbiljnog oštećenja jetre nakon primjene lijeka Esmya (ulipristal acetat).
English: • If no liver problems are detected, a single course of Esmya can be used in women who are about to have surgery for their fibroids; Esmya can be used for more than one course only in women who cannot have surgery.
Croatian: • Ako se ne pokažu problemi s jetrom, moguće je započeti jedan ciklus liječenja u bolesnica koje planiraju operirati miome; Esmya se može upotrijebiti u više ciklusa liječenja samo u bolesnica koje se ne mogu operirati.
English: − Treatment should be stopped in patients with ALT or AST levels more than 3 times ULN.
Croatian: Liječenje treba prekinuti u bolesnika s razinom ALT-a ili AST-a tri puta većom od ULN-a.
English: A letter will be sent to doctors to inform them of the new conditions of use, which will become applicable after a Commission decision is issued.
Croatian: Liječnicima je poslan dopis s obavijesti o novim uvjetima uporabe.
English: The CHMP opinion will now be forwarded to the European Commission, which will issue a final legally binding decision applicable in all EU Member States in due course.
Croatian: Mišljenje CHMP-a proslijeđeno je Europskoj komisiji koja je 26/07/2018. donijela konačnu, pravno obvezujuću odluku koja se primjenjuje u svim državama članicama EU-a.
English: Esmya is used to treat moderate to severe symptoms of uterine fibroids (benign tumours of the womb).
Croatian: Esmya se upotrebljava za liječenje umjerenih do ozbiljnih simptoma mioma maternice (dobroćudni tumori maternice).
English: • The medicine Esmya, used to treat uterine fibroids, has been reviewed because cases of serious liver problems have occurred in women taking the medicine, including four cases that resulted in liver transplantation.
Croatian: • Lijek Esmya koji se primjenjuje za liječenje mioma maternice ocijenjen je zbog ozbiljnih problema s jetrom u bolesnica koje su uzimale lijek, uključujući četiri slučaja u kojima je došlo do transplantacije jetre.
English: • A liver test will be performed before you start treatment and if the test is abnormal, treatment with Esmya will not be started.
Croatian: Ako rezultati budu abnormalni, liječenje lijekom Esmya neće se započeti.
English: • You should stop treatment and contact your doctor immediately if you develop symptoms of liver injury (such as tiredness, yellowing of the skin, darkening of the urine, nausea and vomiting).
Croatian: • Ako se pojave simptomi oštećenja jetre (kao što su umor, žutilo kože, tamniji urin, mučnina i povraćanje), odmah prestanite uzimati lijek i obratite se liječniku.
English: • A card will be included in the package of the medicine with information on the risk of liver injury and the need for liver monitoring.
Croatian: • Kartica s podatcima o opasnosti od oštećenja jetre i potrebi praćenja jetre isporučivat će se u pakiranju lijeka.
English: • Four cases of serious liver injury leading to hepatic transplantation and additional cases of hepatic injury have been reported in patients treated with Esmya (ulipristal acetate).
Croatian: • U bolesnika koji su primali lijek Esmya (ulipristal acetat) zabilježena su četiri slučaja ozbiljnog oštećenja jetre koje je dovelo do transplantacije jetre i dodatni slučajevi oštećenja jetre.
English: − Restricted indication in the intermittent treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age: Esmya should only be used in women who are not eligible for surgical treatment.
Croatian: Ograničena indikacija za povremeno liječenje umjerenih do ozbiljnih simptoma mioma maternice u odraslih bolesnica reproduktivne dobi: Esmya se smije primjenjivati samo u bolesnica koje ne ispunjavaju uvjete za kirurški zahvat. (Lijek Esmya i dalje je indiciran za jedan ciklus (u trajanju do tri mjeseca) predoperativnog liječenja umjerenih do ozbiljnih simptoma mioma maternice u odraslih bolesnica reproduktivne dobi.)
English: In 8 cases of serious liver injury, a role of Esmya in contributing to these cases is possible.
Croatian: Postoji mogućnost da je lijek Esmya pridonio ozbiljnom oštećenju jetre u osam slučajeva.
English: ATCvet code: QI05AD02.
Croatian: ATCvet kod: QI05AD02.
English: Date of first authorisation: 06/03/2003 Date of last renewal: 06/03/2013
Croatian: Datum prvog odobrenja: 06/03/2003 Datum posljednjeg produljenja odobrenja: 06/03/2013
English: 69800 Saint Priest
Croatian: F-69800 Saint Priest
English: After inoculation, the viruses do not multiply in the horse but express the protective proteins.
Croatian: Nakon inokulacije virusi se u konju ne množe ali izražavaju zaštitne proteine.
English: The active substances being a principle of biological origin intended to produce active immunity are not within the scope of Regulation (EC) 470/2009.
Croatian: Djelatne tvari koje se sastoje od tvari biološkog podrijetla, namijenjene za izazivanje aktivne imunosti na koje se ne primjenjuju odredbe Uredbe (EK) 470/2009.
English: In exceptional circumstances, apathy and reduced appetite may be observed the day after vaccination.
Croatian: U izuzetnim okolnostima, može se uočiti apatija i smanjeni tek , dan nakon cijepljenja.
English: Laboratory of Lyon Gerland 254, Avenue Marcel Mérieux 69007 Lyon
Croatian: MERIAL Laboratory of Lyon Gerland 254, Avenue Marcel Mérieux 69007 Lyon, FRANCUSKA
English: Carbomer ........................................................................................................................................... 4 mg.
Croatian: Karbomer ............................................................................................................................................ 4 mg
English: Do not mix with any other veterinary medicinal product.
Croatian: Ne miješati s nekim drugim veterinarsko medicinskim proizvodom.
English: Disodium hydrogen orthophosphate Monopotassium phosphate anhydrous Water for injections
Croatian: Natrijev klorid Dinatrij hidrogenortofosfat Monokalij fosfat anhidrid Voda za injekcije
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGE Outer package for 10 doses: 10 vials of 1 dose
Croatian: PODACI NA VANJSKOM PAKOVANJU Vanjsko pakovanje za 10 doza: 10 bočica s 1 dozom
English: Do not use after the expiry date stated on the label.
Croatian: Ne primjenjivati poslije isteka roka valjanosti naznačenog na etiketi.
English: Active immunisation of horses of 4 months of age or older against equine influenza to reduce clinical signs and virus excretion after infection.
Croatian: Aktivna imunizacija konja starih 4 mjeseca ili starijih protiv influence konja za smanjenje kliničkih znakova i izlučenja virusa nakon infekcije.
English: The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals displaying adverse reaction(s) during the course of one treatment) - common (more than 1 but less than 10 animals in 100 animals) - uncommon (more than 1 but less than 10 animals in 1,000 animals) - rare (more than 1 but less than 10 animals in 10,000 animals) - very rare (less than 1 animal in 10,000 animals, including isolated reports).
Croatian: - vrlo često (više od 1od 10 životinja pokazuje nuspojavu(e) nakon jednokratne primjene) - često (više od 1, ali manje od 10 životinja od 100 životinja) - manje često (više od 1, ali manje od 10 životinja od 1,000 životinja) - rijetko (više od 1, ali manje od 10 životinja od 10,000 životinja) - vrlo rijetko (manje od 1 životinje od 10,000 životinja, uključujući izolirane slučajeve prijave).
English: 2nd scheme - vaccination against equine influenza and tetanus:
Croatian: 2. raspored - cijepljenje protiv influence konja i tetanusa:
English: Manufacturer responsible for the batch release: MERIAL
Croatian: Nositelj odobrenja za proizvodnju za puštanje proizvodne serije: MERIAL
English: Pain, local hyperthermia and muscle stiffness can occur in rare cases.
Croatian: U rijetkim se slučajevima mogu javiti bol i lokalna hipertermija te ukočenost mišića.
English: Duration of immunity induced by the vaccination scheme: 5 months after primary vaccination course and 1 year after the third vaccination.
Croatian: Shema trajanja imuniteta induciranog cijepljenjem: 5 mjeseci nakon prvog cijepljenja i 1 godinu nakon trećeg cijepljenja.
English: In rare occasions swelling can reach a diameter up to 15-20 cm, with duration up to 2-3 weeks, that may require symptomatic treatment.
Croatian: rijetkim slučajevima otok može imati promjer do 15-20 cm u trajanju od 2-3 tjedna kada može biti potrebno simptomatsko liječenje.
English: The excipients, including adjuvants, listed in section 6.1 of the SPC are either allowed substances for which table 1 of the annex to Commission Regulation (EU) No 37/2010 indicates that no MRLs are required or are considered as not falling within the scope of Regulation (EC) No 470/2009 when used as in this product.
Croatian: Pomoćne tvari (uključujući adjuvanse) navedene u dijelu 6.1 SPC su ili dozvoljene tvari za koje je u tablici 1, Dodatka Uredbe Komisije (EU) br. 37/2010 naznačeno da određivanje MRL nije nužno,
English: Laboratoire Porte des Alpes Rue de l'Aviation
Croatian: Rue de l'Aviation
English: A transient swelling which usually regresses within 4 days may appear at the injection site.
Croatian: Na mjestu injiciranja može se pojaviti prolazni otok koji se obično tijekom 4 dana smanjuje.
English: In very rare occasions, abscessation may be observed.
Croatian: Vrlo rijetko mogu se zamijetiti apscesi.
English: The vaccine stimulates active immunity against equine influenza.
Croatian: Cjepivo potiče aktivni imunitet na influencu konja.
English: A slight increase in temperature (max. 1.5 °C) may occur for 1 day, exceptionally 2 days.
Croatian: Može se javiti malo povišenje tjelesne temperature (najviše 1,5°C) tijekom jednog do najviše dva dana nakon cijepljenja.
English: Incompatibilities: Do not mix with any veterinary medicinal product.
Croatian: Ne miješati s bilo kojim drugim veterinarsko-medicinskim proizvodom.
English: MANUFACTURERS OF THE BIOLOGICAL ACTIVE SUBSTANCES AND MANUFACTURER RESPONSIBLE FOR BATCH RELEASE
Croatian: PROIZVOĐAČI BIOLOŠKI DJELATNIH TVARI I PROIZVOĐAČ ODGOVORAN ZA
English: - Revaccination: 5 months after primary vaccination course followed by annual booster injections.
Croatian: - Docjepljivanje: 5 mjeseci nakon prvog cijepljenja a nakon toga docjepljivanje injekcijom jednom godišnje.
English: 1st scheme - vaccination against equine influenza:
Croatian: 1. raspored - cijepljenje protiv influence konja:
English: Influenza A/eq/Ohio/03 [H3N8] (vCP2242) ............................................................... ≥ 5.3 log10 FAID50 Influenza A/eq/Richmond/1/07 [H3N8] (vCP3011) .................................................... ≥ 5.3 log10 FAID50
Croatian: Influenca A/eq/Ohio/03 [H3N8] (vCP2242) ............................................................... ≥ 5,3 log10 FAID50 Influenca A/eq/Richmond/1/07 [H3N8] ( vCP3011) ..................................................
English: A. MANUFACTURERS OF THE BIOLOGICAL ACTIVE SUBSTANCES AND MANUFACTURER RESPONSIBLE FOR BATCH RELEASE
Croatian: DODATAK II A. PROIZVOĐAČI BIOLOŠKI DJELATNIH TVARI I PROIZVOĐAČ ODGOVORAN ZA PUŠTANJE SERIJE U PROMET
English: The vaccine strains vCP2242 and vCP3011 are recombinant canarypox viruses expressing the haemagglutinin HA gene from the equine influenza virus strains A/eq/Ohio/03 (American strain, Florida sublineage clade 1) and A/eq/Richmond/1/07 (American strain, Florida sublineage clade 2), respectively.
Croatian: Sojevi cjepiva vCP2242 i vCP3011su rekombinanti virusa boginja kanarinca koji iz sojeva virusa konjske gripe A/eq/Ohio/03 (američki soj, Florida podlinija „clade 1“) odnosno A/eq/Richmond/1/07 (američki soj, Florida podlinija „clade 2“) izražavaju gen hemaglutinin HA.
English: PACKAGE LEAFLET FOR: ProteqFlu suspension for injection for horses
Croatian: UPUTA O VMP ZA: ProteqFlu suspenzija za injekciju za konje
English: In case of increased infection risk or insufficient colostrum intake, an additional initial injection of ProteqFlu-Te can be given at the age of 4 months followed by the full vaccination programme (primary vaccination course at 5-6 months of age and 4-6 weeks later followed by revaccination).
Croatian: U slučaju povećanog rizika ili nedostatnog uzimanja kolostruma, može se dati dodatna doza cjepiva ProteqFlu-Te u dobi od 4 mjeseca nakon čega slijedi program potpunog cijepljenja (prvo cijepljenje u dobi od 5-6 mjeseci i ponovno cijepljenje 4-6 tjedana kasnije nakon čega slijedi docjepljivanje).
English: In case of increased infection risk or insufficient colostrum intake, an additional initial injection of ProteqFlu can be given at the age of 4 months followed by the full vaccination programme (primary vaccination course at 5-6 months of age and 4-6 weeks later followed by revaccination).
Croatian: U slučaju povećanog rizika ili nedostatnog uzimanja kolostruma, može se dati dodatna doza cjepiva ProteqFlu u dobi od 4 mjeseca nakon čega slijedi program potpunog cijepljenja (prvo cijepljenje u dobi od 5-6 mjeseci i ponovno cijepljenje 4-6 tjedana kasnije nakon čega slijedi docjepljivanje).
English: ProteqFlu suspension for injection for horses
Croatian: ProteqFlu suspenzija za injekcije za konje
English: DOSAGE FOR EACH SPECIES, ROUTE(S) AND METHOD OF ADMINISTRATION 1st scheme - vaccination against equine influenza:
Croatian: DOZIRANJE ZA SVAKU CILJNU VRSTU ŽIVOTINJA, NAČIN I PUT(EVI)
English: Administer one dose (1 ml of ProteqFlu), by intramuscular injection, preferably in the neck region, according to the following schedule: - Primary vaccination course: first injection from 5-6 months of age, second injection 4-6 weeks later.
Croatian: - Prvo cijepljenje s ProteqFlu-Te: prva injekcija u dobi 5-6 mjeseci, druga injekcija 4-6 tjedana kasnije.
English: Sodium chloride
Croatian: KLINIČKE POJEDINOSTI
English: The maximum exposure was 5.6 years.
Croatian: Maksimalna izloženost bila je 5,6 godina.
English: Not all mutations have been tested.
Croatian: Nisu ispitane sve mutacije.
English: This will help you remember which day you did not take the medicine.
Croatian: To će Vam pomoći upamtiti dan kada niste uzeli lijek.
English: This leaflet was last revised in
Croatian: Ova je uputa zadnji put revidirana u
English: The study was structured in two periods.
Croatian: Ispitivanje je bilo strukturirano u dva razdoblja.
English: Titanium dioxide (E171) Indigotine (E132)
Croatian: Titanijev dioksid (E171) Indigotin (E132)
English: You may get a headache and feel dizzy.
Croatian: Mogli biste dobiti glavobolju i osjetiti omaglicu.
English: Tell your doctor, pharmacist or nurse if you are taking, have recently taken, or might take any other medicines because certain other medicines may increase or decrease the amount of Galafold in your body.
Croatian: Obavijestite svog liječnika, ljekarnika ili medicinsku sestru ako uzimate, nedavno ste uzeli ili biste mogli uzeti bilo koje druge lijekove jer određeni drugi lijekovi mogu povećati ili smanjiti količinu lijeka Galafold u Vašem tijelu.
English: For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder (if you cannot reach your Amicus representative by phone please contact via the e-mail address listed below):
Croatian: Za sve informacije o ovom lijeku obratite se lokalnom predstavniku nositelja odobrenja za stavljanje lijeka u promet (ako ne možete stupiti u kontakt sa svojim predstavnikom tvrtke Amicus telefonom, obratite mu se na adresu e-pošte navedenu u nastavku):
English: Capsules must be swallowed whole.
Croatian: Kapsule se moraju progutati cijele.
English: Approximately 9% of the total radioactivity was unassigned.
Croatian: Otprilike 9 % ukupne radioaktivnosti bilo je nedodijeljeno.
English: In case of overdose, general medical care is recommended.
Croatian: U slučaju predoziranja preporučuje se opća medicinska skrb.
English: A pharmacokinetic trial in healthy male volunteers with 150 mg [
Croatian: Farmakokinetičko ispitivanje u zdravih muških dobrovoljaca s dozom od 150 mg [
English: Other medicines and Galafold
Croatian: Drugi lijekovi i Galafold
English: The safety and efficacy of Galafold in children aged 0 to 15 years has not yet been established.
Croatian: Sigurnost i djelotvornost lijeka Galafold u djece u dobi od 0 do 15 godina nisu još ustanovljene.
English: Take at the same time each day.
Croatian: Uzimajte svaki put u isto doba dana.
English: (see section 5.2).
Croatian: (vidjeti dio 5.2).
English: • Protein in the urine
Croatian: • proteini u urinu
English: The capsules must not be cut, crushed, or chewed.
Croatian: Kapsule se ne smiju rezati, drobiti ili žvakati.
English: This medicine has not been studied in children and adolescents under the age of 16 years; therefore, the safety and efficacy in this age group has not been established.
Croatian: Lijek nije ispitan u djece i adolescenata mlađih od 16 godina, stoga nisu utvrđene sigurnost i djelotvornost u toj dobnoj skupini.
English: Clear liquids, including carbonated drinks, can be consumed during this period.
Croatian: Bistre tekućine, uključujući gazirana pića, mogu se konzumirati tijekom tog razdoblja.
English: Frequencies are defined as: very common (≥ 1/10), common (≥ 1/100 to < 1/10), uncommon (≥1/1,000 to <1/100), rare (≥1/10,000 to <1/1,000), very rare (<1/10,000) and not known (cannot be estimated from the available data).
Croatian: Učestalost se određuje kako slijedi: vrlo često (≥ 1/10), često (≥ 1/100 i < 1/10), manje često (≥ 1/1000 i < 1/100), rijetko (≥ 1/10 000 i < 1/1000), vrlo rijetko (< 1/10 000), nije poznato (ne može se procijeniti iz dostupnih podataka).
English: Instructions to open
Croatian: Upute za otvaranje
English: In these cases, the question marks in the accompanying parentheses indicate that the changes provided therein have not been experimentally confirmed and may not be correct.
Croatian: U tim slučajevima upitnici u popratnim zagradama označavaju da promjene koje su tamo istaknute nisu eksperimentalno potvrđene te možda nisu točne.
English: 100 M.
Croatian: 1 i 100 M.
English: On the next day, punch out the perforated white circle labelled Day 2.
Croatian: Sljedeći dan probušite perforirani bijeli krug označen natpisom 2.dan.
English: What you need to know before you take Galafold 3.
Croatian: Što morate znati prije nego počnete uzimati Galafold 3.
English: Fertility in men
Croatian: Plodnost u muškaraca
English: The recommended dosage regimen in adults and adolescents 16 years and older is 123 mg migalastat (1 capsule) once every other day at the same time of day.
Croatian: Preporučeni režim doziranja u odraslih i adolescenata u dobi od 16 godina i starijih jest 123 mg migalastata (1 kapsula) jedanput svaki drugi dan u isto doba dana.
English: Do not cut, crush, or chew the capsule.
Croatian: Nemojte rezati, drobiti i žvakati kapsulu.